Figure 1: (a) Cell and gene therapy development pathway from patient/donor (red) to recipient (blue); (b) subcellular molecules and ions important for effective cell and gene therapy cultures ...

Cell and gene therapies have reached clinical and commercial success as evidenced by the steady number of first approvals over the past four years. Drug developers face mounting challenges linked to ...

Adenoviral vectors are frequently used as gene delivery tools for various medical applications. In most cases, replication-incompetent adenoviruses are employed, which, once they have infected a ...

In the 24th year of this millennium, the biopharma sector navigated seismic shifts, from legislative challenges and technological advancements to restructuring and landmark acquisitions. Together, ...

Be the catalyst for change and experience the future of bioprocessing. Slash biologics development costs, supercharge your pipeline, and deliver transformative therapies with precision, quality, and ...

Explore the latest news and expert commentary on Cell Culture Media, brought to you by the editors of BioProcess International ...

Zuwei Jin, VP of Business Development at LISURE explains the advantages of the M++ system at BioProcess International US West 2025 in San Diego, CA. M++ is a pilot-scale modular benchtop system that ...

Explore the latest news and expert commentary on Separation/Purification, brought to you by the editors of BioProcess International ...

Explore the latest news and expert commentary on Upstream & Downstream Processing, brought to you by the editors of BioProcess International ...

When evaluating a new process for viral vector manufacturing, you may be wondering what the best path forward is to save time and resources while ensuring to produce enough data to support the ...

Isolere Bio is on a mission to transform biomanufacturing and tackle the traditional limitations in downstream processing with its novel IsoTag reagents. This first-of-its-kind technology is based on ...

For determining sample sizes, both nonparametric binomial and exponential chi-squared methods are widely accepted for practice in industries regulated by the US Food and Drug Administration (FDA).